Shares of DexCom Inc. DXCM slipped 1.04% to $69.70 Monday, on what proved to be an all-around positive trading session for ...
Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...
An exciting market opportunity for DexCom is to offer a solution for people who don't require insulin injections or even ...
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...
These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the ...
Stock analysis is all about predictions – but as wits from Mark Twain to Yogi Berra have reminded us, predictions are hard, ...
Zacks.com on MSN11h
TNDM Stock Likely to Gain From Innovation Amid CompetitionTandem Diabetes TNDM is gaining from continued product innovations. Yet, ongoing macroeconomic challenges and tough ...
Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...
No pain, no gain,” that’s what Trivariate Research, a U.S. equity focused research house, highlighted about stocks that have ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $68.94 which represents a decrease of $-1.15 or -1.64% from the prior close of $70.09. The stock opened at $69.99 and touched a low of $68.59 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback